Reneo Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2019
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Founders
- Niall O'Donnell
- Company Description
- Reneo Pharmaceuticals is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. The company's goal is to improve daily function and quality of life of patients suffering from these diseases by improving mitochondrial function and preventing muscle injury, weakness, and wasting.
- Market
- Genetic mitochondrial diseases
- Location
- San Diego, CA, USA
- Coinvestors
- Lundbeckfonden Ventures, New Enterprise Associates, Pappas Capital, RiverVest Venture Partners